AACR visits Washington DC


On January 8, 2016, fifteen distinguished American Association for Cancer Research (AACR) leadership and members including Dr. Arul Chinnaiyan, from 10 cancer centers and medical institutions all across the U.S. (from nine different states) participated in meetings with top officials from the Food and Drug Administration (FDA) to discuss FDA’s current thinking on how the agency might regulate NGS-based tests, as well as interrelated topics, such as laboratory developed tests (LDTs) and companion diagnostics for cancer therapies. The AACR used the meeting as an opportunity to provide information and important perspectives to the FDA as it begins developing NGS-related guidance for the scientific community.

In addition, the AACR team was invited to a separate meeting with senior staffers for Vice President Joe Biden  to discuss ways the Vice President can further his commitment to cancer research. The Vice President believes that his power is in:  1) serving as a convener; 2) influencing Federal agencies; and 3) spurring public-private partnerships; he is specifically interested in determining how to incentivize collaboration and breaking down barriers. 

The AACR  Team was well-received by both the FDA officials as well as the Vice President's staff, the meetings were productive and encouraging.